Search research articles
Contact Us
Filters
Showing results (81-90 of 195) with videos related to
Page
of 20
Sort By:
European Psychiatry : the Journal of the Association of European Psychiatrists
|
May 17, 2011
Remitted but still impaired? Symptomatic versus functional remission in patients with schizophrenia
A Karow, S Moritz, M Lambert, et al.
Pharmacopsychiatry
|
November 19, 2011
Long-Term Assessment of Asenapine vs. Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder
J Schoemaker, D Naber, P Vrijland, et al.
The American Journal of Psychiatry
|
May 1, 1982
Cerebrospinal fluid opioid activity in anorexia nervosa
W H Kaye, D Pickar, D Naber, et al.
Der Nervenarzt
|
May 10, 2013
[Expression, identification and experience of emotions in mental diseases. An overview]
K Wolf, R Maß, M Lambert, et al.
Pharmacopsychiatry
|
March 6, 2010
Long-term assessment of Asenapine vs. Olanzapine in patients with schizophrenia or schizoaffective disorder
J Schoemaker, D Naber, P Vrijland, et al.
Studies in Health Technology and Informatics
|
March 21, 2000
Telepathology and imaging spectroscopy as a new modality in histopathology
S G Vari, G Müller, J M Lerner, et al.
Neuropsychobiology
|
January 1, 1980
Effect of long-term neuroleptic treatment on prolactin and norepinephrine levels in serum of chronic schizophrenics: relations to psychopathology and extrapyramidal symptoms
D Naber, C Finkbeiner, B Fischer, et al.
Der Nervenarzt
|
March 8, 2014
[Long-term treatment of schizophrenia spectrum disorders: focus on pharmacotherapy]
L Deutschenbaur, M Lambert, M Walter, et al.
Neuropharmacology
|
May 1, 1981
Circadian acetylcholine receptor rhythm in rat brain and its modification by imipramine
M S Kafka, A Wirz-Justice, D Naber, et al.
Psychiatry Research
|
September 1, 1986
A double-blind study with ceruletide in chronic schizophrenic patients: biochemical and clinical results
M Albus, K von Gellhorn, U Münch, et al.
Page
of 20
Search research articles
Search
Showing results (81-90 of 195) with videos related to
Sort By:
Page
of 20
European Psychiatry : the Journal of the Association of European Psychiatrists
|
May 17, 2011
Remitted but still impaired? Symptomatic versus functional remission in patients with schizophrenia
A Karow, S Moritz, M Lambert, et al.
Pharmacopsychiatry
|
November 19, 2011
Long-Term Assessment of Asenapine vs. Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder
J Schoemaker, D Naber, P Vrijland, et al.
The American Journal of Psychiatry
|
May 1, 1982
Cerebrospinal fluid opioid activity in anorexia nervosa
W H Kaye, D Pickar, D Naber, et al.
Der Nervenarzt
|
May 10, 2013
[Expression, identification and experience of emotions in mental diseases. An overview]
K Wolf, R Maß, M Lambert, et al.
Pharmacopsychiatry
|
March 6, 2010
Long-term assessment of Asenapine vs. Olanzapine in patients with schizophrenia or schizoaffective disorder
J Schoemaker, D Naber, P Vrijland, et al.
Studies in Health Technology and Informatics
|
March 21, 2000
Telepathology and imaging spectroscopy as a new modality in histopathology
S G Vari, G Müller, J M Lerner, et al.
Neuropsychobiology
|
January 1, 1980
Effect of long-term neuroleptic treatment on prolactin and norepinephrine levels in serum of chronic schizophrenics: relations to psychopathology and extrapyramidal symptoms
D Naber, C Finkbeiner, B Fischer, et al.
Der Nervenarzt
|
March 8, 2014
[Long-term treatment of schizophrenia spectrum disorders: focus on pharmacotherapy]
L Deutschenbaur, M Lambert, M Walter, et al.
Neuropharmacology
|
May 1, 1981
Circadian acetylcholine receptor rhythm in rat brain and its modification by imipramine
M S Kafka, A Wirz-Justice, D Naber, et al.
Psychiatry Research
|
September 1, 1986
A double-blind study with ceruletide in chronic schizophrenic patients: biochemical and clinical results
M Albus, K von Gellhorn, U Münch, et al.
Page
of 20